Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Merck
Johnson and Johnson
Cantor Fitzgerald
UBS
Cipla
Daiichi Sankyo
Moodys

Generated: November 17, 2018

DrugPatentWatch Database Preview

Filgrastim - Biologic Drug Details

« Back to Dashboard

Summary for filgrastim
Tradenames:1
Patents:170
Applicants:1
BLAs:1
Suppliers: see list1

US Patents for filgrastim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Try a Free Trial University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Try a Free Trial Washington University (St. Louis, MO) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for filgrastim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90052-6 Sweden ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928 20140522
299044 Germany ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
00687 Netherlands ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
02C/040 Belgium ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; AUTHORISATION NUMBER AND DATE: EU/1/02/227/001 20020823
C0048 France ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Teva
Queensland Health
Argus Health
Fuji
Chubb
Boehringer Ingelheim
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.